Genome & Company (KOSDAQ: 314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,915.00
-15.00 (-0.51%)
Nov 15, 2024, 9:00 AM KST

Genome & Company Market Cap

Genome & Company has a market cap or net worth of 90.43 billion as of November 18, 2024. Its market cap has decreased by -45.61% in one year.

Market Cap
90.43B
Enterprise Value
87.83B
Revenue
23.92B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,915.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 90.43B, an increase of 25.82%. That is a compound annual growth rate of 3.97%.

History

DateMarket Cap% Change
Nov 15, 202490.28B-48.77%
Dec 28, 2023176.21B-28.34%
Dec 29, 2022245.90B-47.55%
Dec 30, 2021468.83B-55.28%
Dec 30, 20201,048.46B224.28%
Dec 30, 2019323.32B241.20%
Dec 28, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition